BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 1, 2012
View Archived Issues
BMS and Duke Translational Medicine Institute broaden their collaboration
Read More
Researchers identify biomarker for ulcer-type interstitial cystitis
Read More
Potassium channel blocker has antiobesity effects in animal models
Read More
Collaborating Australian universities design new candidate schizophrenia therapies
Read More
New marker and potential therapeutic target identified for castration-resistant prostate cancer
Read More
AVI BioPharma clear to proceed with studies of AVI-6003 component
Read More
Merck & Co. designs new products with potential to treat hepatitis C
Read More
Amgen divulges novel beta-secretase 1 inhibitors
Read More
Novel ALK inhibitors created with anticancer potential
Read More
Merck KGaA reports new P70S6K inhibitors
Read More
Novel protease-activated PAR2 receptor ligands developed in Australia
Read More
New protein kinase inhibitors identified at Nerviano Medical Sciences
Read More
Dainippon Sumitomo Pharma reaches agreement on acquisition
Read More
OncoTherapy Science updates on cancer peptide vaccine pipeline
Read More
BCI-838 enters new phase I trial
Read More
Shire and arGEN-X to develop therapeutic antibodies for rare diseases
Read More
Creabilis begins phase IIb CT-327 study
Read More
Biotie completes PET imaging study of serotonin 5-HT6 receptor antagonist
Read More
Essentialis reports results from phase IIb trial of DCCR
Read More
Baxter International begins study of stem cell therapy for chronic myocardial ischemia
Read More
FDA accepts Tau Therapeutics' IND for repositioned drug
Read More
Johns Hopkins and ImmunoCellular Therapeutics enter licensing agreement for cancer antigen
Read More
Polaris begins dosing in study of cancer therapy in pediatric patients
Read More
Global rights to biocrea phosphodiesterase program transferred
Read More
FDA grants orphan drug status to treatment for lysosomal storage disorder
Read More
Avanir and Concert Pharmaceuticals to develop deuterium-modified dextromethorphan
Read More